Approximately 75 % of a series of over 200 human solid neoplasms were sensitive to either hyperthermia (42°C) or cytotoxic drug(s), or a combination of these, as defined by a 30% or greater inhibition of respiration and/or anaerobic glycolysis brought about by the agent in fresh and/or cultured tumour.
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The inhibition was paralleled by decreased radioactive precursor incorporation into DNA, RNA and protein by the tumour slices. In a solid Yoshida rat tumour there was close correlation between the biochemical response in vitro to heat and drugs and the in vivo response of the tumour. Sensitivity in this system is taken to indicate a drug and/or heat responsive cell population within the tumour. The extent to which such a result predicts patient response will depend upon the existence or emergence of resistant cells in the tumour in vivo, and on the sensitivity of metastatic cells. Recently Ross and co-workers (Bukhari, Everett and Ross, Biochem. Pharmac., 1971, 21, 963) published the syntheses of 3 conjugates of p-hydroxyaniline mustard which they suggested might be selective for tumours with high levels of ,B-glucuronidase, phosphatase and sulphatase. The 0-glucuronide, 0-phosphate and 0-sulphate respectively were expected to be deconjugated in vivo by the appropriate enzymes. High enzyme activity in a particular tumour could lead to selectivity of action due to the greater release of the rapidly reacting p-hydroxyaniline mustard in the tumour than elsewhere.
We have determined the ability of the appropriate enzymes to utilize these drugs (kindly supplied by Professor Ross) as sub-
